Perinatal Choline Supplementation Reduces Amyloidosis and Increases Cholinergic Marker Expression in the Hippocampus of the APPswePS1dE9 Alzheimer's Disease Model Mice

被引：0
|
作者：
Mellott, Tiffany [1 ]
Huleatt, Olivia [1 ]
Shade, Bethany [1 ]
Pender, Sarah [1 ]
Liu, Yi Bessie [1 ]
Blusztajn, Jan [1 ]
机构：
[1] Boston Univ, Sch Med, Pathol & Lab Med, Boston, MA 02118 USA
来源：
FASEB JOURNAL | 2015年 / 29卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
900.1
引用
收藏
页数：1
相关论文
共 47 条
  • [1] Perinatal Choline Supplementation Reduces Amyloidosis and Increases Choline Acetyltransferase Expression in the Hippocampus of the APPswePS1dE9 Alzheimer's Disease Model Mice (vol 12, e0170450, 2017)
    Mellott, Tiffany J.
    Huleatt, Olivia M.
    Shade, Bethany N.
    Pender, Sarah M.
    Liu, Yi B.
    Slack, Barbara E.
    Blusztajn, Jan K.
    PLOS ONE, 2017, 12 (03):
  • [2] Perinatal Choline Supplementation Reduces Amyloidosis and Increases Choline Acetyltransferase Expression in the Hippocampus of the APPswePS1 dE9 Alzheimer's Disease Model Mice
    Mellott, Tiffany J.
    Huleatt, Olivia M.
    Shade, Bethany N.
    Pender, Sarah M.
    Liu, Yi B.
    Slack, Barbara E.
    Blusztajn, Jan K.
    PLOS ONE, 2017, 12 (01):
  • [3] IGF2 Ameliorates Amyloidosis, Increases Cholinergic Marker Expression and Raises BMP9 and Neurotrophin Levels in the Hippocampus of the APPswePS1dE9 Alzheimer's Disease Model Mice
    Mellott, Tiffany J.
    Pender, Sarah M.
    Burke, Rebecca M.
    Langley, Erika A.
    Blusztajn, Jan Krzysztof
    PLOS ONE, 2014, 9 (04):
  • [4] YXQN Reduces Alzheimer's Disease-Like Pathology and Cognitive Decline in APPswePS1dE9 Transgenic Mice
    Wang, Xiaowan
    Song, Runmin
    Lu, Wenliang
    Liu, Ziyu
    Wang, Lichun
    Zhu, Xiaojuan
    Liu, Yanjun
    Sun, Zijie
    Li, Jiang
    Li, Xiaomeng
    FRONTIERS IN AGING NEUROSCIENCE, 2017, 9
  • [5] Differential cell proliferation in the cortex of the appsweps1de9 alzheimer's disease mouse model
    Kamphuis, Willem
    Orre, Marie
    Kooijman, Lieneke
    Dahmen, Maurice
    Hol, Elly M.
    GLIA, 2012, 60 (04) : 615 - 629
  • [6] Hippocampal and cortical EEG frequency alterations in the APPswePS1dE9 model of Alzheimer's disease
    Weiergraeber, M.
    Soos, J.
    Lundt, A.
    Wormuth, C.
    Mueller, R.
    Henseler, C.
    Broich, K.
    Papazoglou, A.
    ACTA PHYSIOLOGICA, 2017, 219 : 42 - 42
  • [7] Study of cognitive performance and effects of pharmacological inhibition of PKR in the APPswePS1dE9 mouse model for Alzheimer's disease
    Couturier, J.
    Page, G.
    Perault-Pochat, M.
    Pontcharraud, R.
    Ingrand, I.
    Fauconneau, B.
    Lafay-Chebassier, C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 : 77 - 77
  • [8] Gender-Specific Hippocampal Dysrhythmia and Aberrant Hippocampal and Cortical Excitability in the APPswePS1dE9 Model of Alzheimer's Disease
    Papazoglou, Anna
    Soos, Julien
    Lundt, Andreas
    Wormuth, Carola
    Ginde, Varun Raj
    Mueller, Ralf
    Henseler, Christina
    Broich, Karl
    Xie, Kan
    Ehninger, Dan
    Haenisch, Britta
    Weiergräber, Marco
    NEURAL PLASTICITY, 2016, 2016
  • [9] Pharmacological Inhibition of PKR in APPswePS1dE9 Mice Transiently Prevents Inflammation at 12 Months of Age but Increases Aβ42 Levels in the Late Stages of the Alzheimer's Disease
    Couturier, Julien
    Paccalin, Marc
    Lafay-Chebassier, Claire
    Chalon, Sylvie
    Ingrand, Isabelle
    Pinguet, Jeremy
    Pontcharraud, Raymond
    Guillard, Olivier
    Fauconneau, Bernard
    Page, Guylene
    CURRENT ALZHEIMER RESEARCH, 2012, 9 (03) : 344 - 360
  • [10] Reactive astrocytes as treatment targets in Alzheimer's disease-Systematic review of studies using the APPswePS1dE9 mouse model
    Smit, Tamar
    Deshayes, Natasja A. C.
    Borchelt, David R.
    Kamphuis, Willem
    Middeldorp, Jinte
    Hol, Elly M.
    GLIA, 2021, 69 (08) : 1852 - 1881
12345